|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Foss KM, Sima C, Ugolini D, Neri M, Allen
KE and Weiss GJ: miR-1254 and miR-574-5p: serum-based microRNA
biomarkers for early-stage non-small cell lung cancer. J Thorac
Oncol. 6:482–488. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Verdecchia A, Francisci S, Brenner H,
Gatta G, Micheli A, Mangone L and Kunkler I; EUROCARE-4 Working
Group: Recent cancer survival in Europe: a 2000–02 period analysis
of EUROCARE-4 data. Lancet Oncol. 8:784–796. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhao G, Cai C, Yang T, Qiu X, Liao B, Li
W, Ji Z, Zhao J, Zhao H, Guo M, et al: MicroRNA-221 induces cell
survival and cisplatin resistance through PI3K/Akt pathway in human
osteosarcoma. PLoS One. 8:e539062013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mendell JT and Olson EN: MicroRNAs in
stress signaling and human disease. Cell. 148:1172–1187. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pillai RS: MicroRNA function: Multiple
mechanisms for a tiny RNA? RNA. 11:1753–1761. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shimono Y, Zabala M, Cho RW, Lobo N,
Dalerba P, Qian D, Diehn M, Liu H, Panula SP, Chiao E, et al:
Downregulation of miRNA-200c links breast cancer stem cells with
normal stem cells. Cell. 138:592–603. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sassen S, Miska EA and Caldas C: MicroRNA:
implications for cancer. Virchows Arch. 452:1–10. 2008. View Article : Google Scholar
|
|
10
|
Engels BM and Hutvagner G: Principles and
effects of microRNA-mediated post-transcriptional gene regulation.
Oncogene. 25:6163–6169. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rodriguez A, Griffiths-Jones S, Ashurst JL
and Bradley A: Identification of mammalian microRNA host genes and
transcription units. Genome Res. 14:1902–1910. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hayes J, Peruzzi PP and Lawler S:
MicroRNAs in cancer: Biomarkers, functions and therapy. Trends Mol
Med. 20:460–469. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mishra PJ and Merlino G: MicroRNA
reexpression as differentiation therapy in cancer. J Clin Invest.
119:2119–2123. 2009.PubMed/NCBI
|
|
15
|
Schmittgen TD: Regulation of microRNA
processing in development, differentiation and cancer. J Cell Mol
Med. 12:1811–1819. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ding M, Qiu TF and Zhou PG: microRNA-449a
suppresses non-small cell lung cancer. Cell Biochem Biophys.
71:1255–1259. 2015. View Article : Google Scholar
|
|
17
|
Li J, Li P, Chen T, Gao G, Chen X, Du Y,
Zhang R, Yang R, Zhao W, Dun S, et al: Expression of microRNA-96
and its potential functions by targeting FOXO3 in non-small cell
lung cancer. Tumour Biol. 36:685–692. 2015. View Article : Google Scholar
|
|
18
|
Zhu D, Chen H, Yang X, Chen W, Wang L, Xu
J and Yu L: Decreased microRNA-224 and its clinical significance in
non-small cell lung cancer patients. Diagn Pathol. 9:1982014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gu Y, Cheng Y, Song Y, Zhang Z, Deng M,
Wang C, Zheng G and He Z: MicroRNA-493 suppresses tumor growth,
invasion and metastasis of lung cancer by regulating E2F1. PLoS
One. 9:e1026022014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jiang J, Lv X, Fan L, Huang G, Zhan Y,
Wang M and Lu H: MicroRNA-27b suppresses growth and invasion of
NSCLC cells by targeting Sp1. Tumour Biol. 35:10019–10023. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yu SH, Zhang CL, Dong FS and Zhang YM:
miR-99a suppresses the metastasis of human non-small cell lung
cancer cells by targeting AKT1 signaling pathway. J Cell Biochem.
116:268–276. 2015. View Article : Google Scholar
|
|
22
|
Zhong K, Chen K, Han L and Li B:
microRNA-30b/c inhibits non-small cell lung cancer cell
proliferation by targeting Rab18. BMC Cancer. 14:7032014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lo SS, Hung PS, Chen JH, Tu HF, Fang WL,
Chen CY, Chen WT, Gong NR and Wu CW: Overexpression of miR-370 and
downregulation of its novel target TGFβ-RII contribute to the
progression of gastric carcinoma. Oncogene. 31:226–237. 2012.
View Article : Google Scholar
|
|
24
|
Yungang W, Xiaoyu L, Pang T, Wenming L and
Pan X: miR-370 targeted FoxM1 functions as a tumor suppressor in
laryngeal squamous cell carcinoma (LSCC). Biomed Pharmacother.
68:149–154. 2014. View Article : Google Scholar
|
|
25
|
Inoue Ji, Ishida T, Tsukamoto N, Kobayashi
N, Naito A, Azuma S and Yamamoto T: Tumor necrosis factor
receptor-associated factor (TRAF) family: adapter proteins that
mediate cytokine signaling. Exp Cell Res. 254:14–24. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Namjou B, Choi CB, Harley IT,
Alarcón-Riquelme ME, Kelly JA, Glenn SB, Ojwang JO, Adler A, Kim K,
Gallant CJ, et al: Evaluation of TRAF6 in a large multiancestral
lupus cohort. Arthritis Rheum. 64:1960–1969. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xie P: TRAF molecules in cell signaling
and in human diseases. J Mol Signal. 8:72013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Camilleri-Broët S, Cremer I, Marmey B,
Comperat E, Viguié F, Audouin J, Rio MC, Fridman WH, Sautès-Fridman
C and Régnier CH: TRAF4 overexpression is a common characteristic
of human carcinomas. Oncogene. 26:142–147. 2007. View Article : Google Scholar
|
|
29
|
Rhodes DR, Yu J, Shanker K, Deshpande N,
Varambally R, Ghosh D, Barrette T, Pandey A and Chinnaiyan AM:
Large-scale meta-analysis of cancer microarray data identifies
common transcriptional profiles of neoplastic transformation and
progression. Proc Natl Acad Sci USA. 101:9309–9314. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang J, Li X, Yang W, Jiang X and Li N:
TRAF4 promotes tumorigenesis of breast cancer through activation of
Akt. Oncol Rep. 32:1312–1318. 2014.PubMed/NCBI
|
|
31
|
Rivas-Perez H and Nana-Sinkam P:
Integrating pulmonary rehabilitation into the multidisciplinary
management of lung cancer: A review. Respir Med. 109:437–442. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Stinchcombe TE: Recent advances in the
treatment of non-small cell and small cell lung cancer. F1000Prime
Rep. 6:1172014. View
Article : Google Scholar
|
|
33
|
Winter J, Jung S, Keller S, Gregory RI and
Diederichs S: Many roads to maturity: microRNA biogenesis pathways
and their regulation. Nat Cell Biol. 11:228–234. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Geng Q, Fan T, Zhang B, Wang W, Xu Y and
Hu H: Five microRNAs in plasma as novel biomarkers for screening of
early-stage non-small cell lung cancer. Respir Res. 15:1492014.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tafsiri E, Darbouy M, Shadmehr MB,
Zagryazhskaya A, Alizadeh J and Karimipoor M: Expression of miRNAs
in non-small-cell lung carcinomas and their association with
clinicopathological features. Tumour Biol. 36:1603–1612. 2015.
View Article : Google Scholar
|
|
36
|
Gu X, Coates PJ, MacCallum SF, Boldrup L,
Sjöström B and Nylander K: TRAF4 is potently induced by TAp63
isoforms and localised according to differentiation in SCCHN.
Cancer Biol Ther. 6:1986–1990. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Rozan LM and El-Deiry WS: Identification
and characterization of proteins interacting with Traf4, an
enigmatic p53 target. Cancer Biol Ther. 5:1228–1235. 2006.
View Article : Google Scholar : PubMed/NCBI
|
